Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6981 matches for

FCDO Minister meets with vaccine researchers

Researchers from the Department of Paediatrics today welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.

First in-human vaccine trial for Nipah virus

The University of Oxford has launched a new clinical trial to test a vaccine against the deadly Nipah virus.

DoP professor named in New Year's Honours list

Matthew Snape, Professor of Paediatrics and Vaccinology at the Oxford Vaccine Group (OVG) before moving to Moderna in August 2022, has been appointed Member of the Most Excellent Order of the British Empire (MBE) for services to Public Health, particularly during COVID-19 while working at the OVG.

OVG receives £7.8 million in research funding to fight pandemic and epidemic threats

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

New campaign by Oxford Vaccine Group hopes to boost jab numbers

Experts have launched a new campaign in a bid to boost waning vaccine uptake by giving people more information about how clinical trials work. Researchers hope to alleviate hesitancy by showing with a simple animation and comic the complex way vaccines are developed.

Chancellor announces support for Rare Therapies Launch Pad

The Chancellor's Autumn statement announced government support for the Rare Therapies Launch Pad, a new programme within the Department of Paediatrics designed to develop regulatory pathways for children with rare conditions to access individualised therapies.

DoP researcher awarded prestigious NIHR professorship

Daniela Ferreira, Professor of Respiratory Infection and Vaccinology at the University of Oxford’s Department of Paediatrics and the Department of Clinical Sciences at the Liverpool School of Tropical Medicine has been awarded one of six prestigious Research Professorships by the National Institute of Health and Care Research (NIHR).

Professor Rebeccah Slater presented with Excellent Supervisor Award

Rebeccah Slater, Professor of Paediatric Neuroscience, Senior Wellcome Fellow and Chair of the Department of Paediatrics’ Equality, Diversity and Inclusivity Committee, has been presented with the Excellent Supervisor Award by the Head of the Medical Sciences Division (MSD).

Oxford welcomes global pandemic experts for focus on 100 Days Mission

Experts linked to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories this week as part of a two-day gathering on accelerating pandemic preparedness.

CEPI funding announced for development of vaccine prototype

The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) today announced the launch of a new project to initiate early development of prototype vaccines against the Junín virus, selected as an exemplar of the Arenavirus family which is responsible for multiple deadly haemorrhagic fevers with epidemic and pandemic potential.

Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines

A pioneering study into human immunity is being launched today by Oxford Vaccine Group at the University of Oxford. The study, called LEGACY03, is being funded by the Medical Research Council part of UK Research and Innovation. By investigating how lymph nodes work, and how they make responses to vaccines in younger and older people, it has the potential to improve vaccine design for different age groups significantly.

The Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases

The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.

Future of Chair in Global Health secured with £5 million gift

The University of Oxford’s commitment to tackling major global health challenges has been strengthened following the endowment of a chair in global health and clinical development. The new permanent post was made possible by a £5 million donation from Brazilian healthcare organisation SAIL for Health.

First vaccine trial in older people launched for Middle East Respiratory Syndrome (MERS)

Researchers at the University of Oxford's Pandemic Sciences Institute have launched a new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS).

Anindita Roy appointed Professor of Paediatric Haematology

The Department of Paediatrics at the University of Oxford is delighted to announce that Anindita Roy has been named Professor of Paediatric Haematology at the University of Oxford.

First in-human trials commence for CCHF vaccine

A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to human volunteers for the first time. The clinical trial of the ChAdOx2 CCHF vaccine aims to confirm its safety and understand how individuals develop immunity following vaccination.

University of Oxford partners with CEPI to counter the threat of future pandemics

The University of Oxford and the Coalition for Epidemic Preparedness Innovations (CEPI) have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.

New study to test babies for Spinal Muscular Atrophy

Scientists at the University of Oxford are running a study at participating hospitals in the Thames Valley and Wessex regions, offering parents the ability to have their newborn baby’s blood tested for Spinal Muscular Atrophy (SMA), in addition to the nine other conditions that are already tested for.

Director of Global Operations at OVG recognised in the King’s Birthday Honours 2023

Dr Parvinder Aley, Director of Global Operations at the Oxford Vaccine Group, has been recognised and celebrated in the 2023 King’s Birthday Honours list. Dr Aley has been appointed an Officer of the Order of the British Empire (OBE) for services to vaccination during the COVID-19 pandemic.

IET award for Paediatrics student

Simon Marchant, a DPhil student at the Paediatric Neuroimaging Group [https://neuroimaging.paediatrics.ox.ac.uk/], has been awarded the Postgraduate Research Award by the Institute of Engineering and Technology. The award, worth £2,500, was given in recognition of his outstanding engineering research in the field of paediatric neuroimaging.

Load More